NAGENasdaq United States
Market cap
$246.873 M
$3.12 +2.63%
Close of 7 Aug 2026
Revenue
$129.4M
#2441 by revenue
Earnings
$17.4M
#1922 by earnings
Shares outstanding
79,126,002
Latest filing cover page
P/E ratio
14.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Niagen Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.